30243Y4
Transfusion Central Vein to Allogeneic, Unspecified with Stem Cells, Hematopoietic, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | 0 Circulatory |
| Operation | 2 Transfusion |
| Body Part | 4 Central Vein |
| Approach | 3 Percutaneous |
| Device | Y Stem Cells, Hematopoietic |
| Qualifier | 4 Allogeneic, Unspecified |
Operation Definition
Putting in blood or blood products
Procedure Overview
Transfusion is the administration of blood or a blood-derived product directly into a patient's circulation, most commonly packed red blood cells, platelets, fresh frozen plasma, or cryoprecipitate. It is used to treat significant blood loss, severe anemia, clotting disorders, or shortages of specific blood components caused by disease or treatment such as chemotherapy.
For a patient, a transfusion means receiving donated or, less commonly, their own previously collected blood through an intravenous line. The goal is to quickly restore oxygen-carrying capacity, clotting ability, or blood volume when the body cannot do so on its own. Transfusions are generally short procedures performed at the bedside, though the underlying condition prompting them can range from routine surgical blood loss to a life-threatening hemorrhage.
Anatomy & Axis Detail
Central Vein
A central vein, typically accessed via a catheter placed in the subclavian, internal jugular, or femoral vein with its tip terminating near the heart, provides high-flow access suited to rapid or large-volume blood product administration. Central venous transfusion is chosen when peripheral veins are inadequate, when massive transfusion protocols demand fast delivery, or when a patient already has central access for other therapy such as chemotherapy or dialysis. Because the catheter tip sits in a high-flow vessel, it tolerates viscous products like packed red cells or platelets with less risk of infiltration than a peripheral line, though it carries greater risk of catheter-related bloodstream infection. Documentation should identify the substance given and confirm the central location of the access device, distinguishing this route from peripheral vein transfusion for coding purposes.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: Stem Cells, Hematopoietic
Stem Cells, Hematopoietic denotes infusion of blood-forming progenitor cells collected from bone marrow or mobilized peripheral blood, used in autologous or allogeneic transplantation to restore marrow function after myeloablative therapy. It is the general hematopoietic stem cell product code, distinguished from the cord blood-derived and T-cell depleted variants by source and processing rather than by clinical indication.
Qualifier: Allogeneic, Unspecified
This qualifier specifies that a transplanted substance, most often hematopoietic stem cells, came from a genetically non-identical donor whose relationship to the recipient was not documented as related or unrelated. It is used in Administration when donor-relationship detail is unavailable in the record. It differs from the more specific allogeneic-related and allogeneic-unrelated qualifiers by leaving that distinction open.
Coding & Documentation
Assigning a code from this family depends on documentation specifying the exact blood product given, whether it was autologous or from a donor, and the vessel or route used for infusion, such as a peripheral vein or central venous catheter. Nursing and physician notes recording units transfused, product type, and any reaction are the primary support for the code. A recurring error is selecting the wrong substance qualifier, for example coding platelets when frozen plasma was actually given, or overlooking that autologous blood requires a different qualifier than banked donor blood. Coders should also confirm the route matches what is documented rather than defaulting to peripheral vein.